Cathrin Petty is a Managing Partner and Global Head of Healthcare at CVC, a global leader in private equity and credit. A healthcare investment specialist, Cathrin joined the firm in 2016 with the aim of increasing CVC’s exposure to the healthcare sector.
CVC's Managing Partners aim to generate risk-adjusted returns across multiple sectors, including healthcare. As pressure on global health systems and rapidly changing technology transforms the way people approach healthcare, Cathrin is well-positioned to make the most of these investment opportunities.
During more than 20 years in the European healthcare sector, Cathrin has worked with both governments and corporations and, since joining CVC, she has overseen numerous deals in the sector, including investments in Theramex, FutureLife, Rayner, Sebia, Recordati, System C, Graphnet and Medivet.
Prior to CVC, Cathrin worked at J.P. Morgan as Head of Healthcare in the EMEA region. Previously she was a Partner at Apax Partners for more than a decade, served as a Non-Executive Director of Greater London’s Strategic Healthcare Authority,...Cathrin Petty is a Managing Partner and Global Head of Healthcare at CVC, a global leader in private equity and credit. A healthcare investment specialist, Cathrin joined the firm in 2016 with the aim of increasing CVC’s exposure to the healthcare sector.
CVC's Managing Partners aim to generate risk-adjusted returns across multiple sectors, including healthcare. As pressure on global health systems and rapidly changing technology transforms the way people approach healthcare, Cathrin is well-positioned to make the most of these investment opportunities.
During more than 20 years in the European healthcare sector, Cathrin has worked with both governments and corporations and, since joining CVC, she has overseen numerous deals in the sector, including investments in Theramex, FutureLife, Rayner, Sebia, Recordati, System C, Graphnet and Medivet.
Prior to CVC, Cathrin worked at J.P. Morgan as Head of Healthcare in the EMEA region. Previously she was a Partner at Apax Partners for more than a decade, served as a Non-Executive Director of Greater London’s Strategic Healthcare Authority, and held positions at Vitruvian Partners and Schroder Ventures/Permira.
Cathrin currently sits on the Boards of Spectrum Medical Group, System C, Recordati, Theramex and Sebia and has held several non-executive positions, including at Intercell, Qualitest and Icon plc. She is chair of CVC’s Diversity and Inclusion Committee.
Away from work, Cathrin sits on the corporate board of Great Ormond Street Hospital, and is a member of Level20’s advisory board and the Lifesciences Advisory Council. An accomplished sportswoman, Cathrin was awarded six Cambridge Blues and represented Wales in both hockey and tennis.
Cathrin holds a master’s degree in Natural Sciences from Cambridge University, and a post-graduate diploma in Management Studies from Cambridge Judge Business School.READ MOREVIEW LESS
Multinational investment bank J.P. Morgan is a leader in financial services. It offers banking solutions to some of the world's biggest and most influential companies, institutions and governments.
Vitruvian is a global investment firm that helps the most talented and ambitious entrepreneurs and businesses achieve their goals. The company invests in growth capital investments and dynamic situation buyouts.
Apax Partners is a leading private equity advisory company. It invests in business, healthcare and financial services; technology; and the consumer and retail sectors.
SV Health Investors is a healthcare fund manager that invests in a variety of stages and sectors. It aims to transform the healthcare industry by supporting diverse entrepreneurs from across the globe.
British global asset management firm Schroders plc was formed in 1804. It assists individuals, intermediaries and institutions from across the globe to meet their investment goals.
Comprised of senior leaders and colleagues from across the CVC network, CVC’s Diversity, Equity & Inclusion Committee acts as a catalyst for change at CVC. CVC’s commitment to diversity, equal opportunities and inclusion extends to their portfolio companies.
Spectrum Medical was founded by Steve Turner and Mark Drain in 2005 and has grown rapidly over the last few years, developing pioneering technologies in the ICU and cardiac bypass space.
FutureLife is a leading provider of IVF and related genetic services. Headquartered in Prague, the company has more than 34 clinics in eight countries and employs over 1,000 people.
Rayner is the UK’s only producer of intraocular lenses. Headquartered in Worthing, West Sussex, the company’s ophthalmic solutions and intraocular lenses are designed to provide patients and surgeons with the best possible visual results.
Recordati is a global pharmaceutical company committed to the R&D, production and marketing of medication. Operating in Europe, Asia, and North and South America, Recordati is headquartered in Milan, Italy.
Sebia is a prominent provider of clinical protein electrophoresis equipment and reagents for the screening and monitoring of various diseases, primarily in the areas of oncology (multiple myeloma), diabetes, hemoglobinopathy, and other unusual pathologies.
System C is a leading services and software company supplying solutions to the health and social care sectors. Founded in 1983, the British company provides systems implementation expertise, innovative IT solutions, and workable consultancy services.
The Department of Health and Social Care, and by extension the Strategic Health Authority for Greater London, assists ministers in leading the nation's health and social care systems in order to help people live more independent, healthier lives for longer.
Established in 1990, ICON plc is a global consulting firm that provides outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and public health organisations as well as governments.
Qualitest is an IT services and consultancy firm that prides itself on providing excellent AI-powered engineering service to its customers.
Zeneus Pharma
Non-Executive Board Member
London, UK
Zeneus Pharma was the manufacturer of biopharmaceutical products in Europe. The company had significant clinical, regulatory, sales, and marketing operations before it was acquired by Cephalon in 2005.
Intercell AG was a Vienna-based biotechnology company that specialised in the development of modern prophylactic and therapeutic vaccines against infectious diseases. In 2012, the company merged with Vivalis to form Valneva SE.
Established in 1992, Sciensus (previously known as Healthcare at Home) gives patients the life-changing treatment they need in the comfort and convenience of their own homes. The organisation connects with people powerfully and personally, focusing on their unique needs.
The Lifesciences Advisory Council was formed to support the promotion of the Cambridge ecosystem, one of the foremost life sciences clusters in the world, to both talent and investment. The council will also advise the ecosystem players on strategy and plans to remain globally competitive.
Set up in 2015, Level 20 is a not-for-profit organisation that aims to encourage more women to not only join the private equity industry, but to succeed in it too.
Great Ormond Street Hospital, located in London, is a children’s hospital and research centre. It is the largest research centre focusing on childhood illness outside of Canada and the US.
Cathrin, in her role as Head of European Healthcare at CVC, discusses the importance of operational partnerships between private equity firms and healthcare manufacturers.
Page Executive offers a variety of search, selection, and talent management solutions to organisations that need to hire permanent or interim executives. Cathrin speaks to Laura Duerr about her experience as a female executive.
In private equity there are many uncertainties and influencing trends to consider, as well as how to be flexible in order to accept them. Cathrin sits on a panel at the 2017 SuperInvestor conference to debate this topic.
View allHide
Features
A bubble ready to burst?
Speaker
Nov 2021
London, UK
Cathrin and her fellow speakers at the FT Live Global Dealmaking Summit discuss the current 'bubble' within the private equity market and the positives and negatives thereof.
The publication of the '100 Most Influential Women in European Finance' marks a watershed moment in the advancement of women into top positions in the otherwise male-dominated financial services industry.
